Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Corvus Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 62
- +16 vs. Q2 2024
- Shares held
- 30.0M
- +3.00M (+11.1%) vs. Q2 2024
- Total value
- $158.5M
- +$109.3M (+222.3%) vs. Q2 2024
- New holders
- 19
- 17 more added
- Sold out
- 3
- 9 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 173 | $1.06B |
| Q1 2026 | 164 | $1.02B |
| Q4 2025 | 124 | $359.4M |
| Q3 2025 | 103 | $312.7M |
| Q2 2025 | 92 | $167.1M |
| Q1 2025 | 88 | $115.4M |
| Q4 2024 | 86 | $202.0M |
| Q3 2024 | 62 | $158.5M |
| Q2 2024 | 47 | $50.2M |
| Q1 2024 | 47 | $31.9M |
| Q4 2023 | 48 | $33.8M |
| Q3 2023 | 52 | $28.0M |
| Q2 2023 | 52 | $44.6M |
| Q1 2023 | 37 | $18.9M |
| Q4 2022 | 42 | $18.2M |
| Q3 2022 | 48 | $18.1M |
| Q2 2022 | 47 | $25.4M |
| Q1 2022 | 57 | $44.9M |
| Q4 2021 | 62 | $66.7M |
| Q3 2021 | 61 | $136.4M |
| Q2 2021 | 50 | $63.2M |
| Q1 2021 | 49 | $62.8M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 6,943,654 | $36.7M | 0.67% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 5,562,729 | $29.4M | 0.10% | −401,781−6.7% | Reduced |
| Samlyn Capital, LLC | 4,530,333 | $23.9M | 0.39% | −1,592,688−26.0% | Reduced |
| Adams Street Partners LLC | 3,275,616 | $17.3M | 9.52% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,420,619 | $12.8M | 0.00% | +770,119+46.7% | Added |
| Vivo Capital, LLC | 1,497,268 | $7.91M | 0.65% | +1,497,268 | New |
| BlackRock, Inc. | 603,877 | $3.19M | 0.00% | +603,877 | New |
| Geode Capital Management, LLC | 563,009 | $2.97M | 0.00% | +102,869+22.4% | Added |
| Ghost Tree Capital, LLC | 500,000 | $2.64M | 0.90% | +500,000 | New |
| Morgan Stanley | 393,262 | $2.08M | 0.00% | +21,859+5.9% | Added |
| Renaissance Technologies LLC | 386,588 | $2.04M | 0.00% | −177,344−31.4% | Reduced |
| Goldman Sachs Group Inc | 376,121 | $1.99M | 0.00% | +376,121 | New |
| Schonfeld Strategic Advisors LLC | 331,360 | $1.75M | 0.01% | +331,360 | New |
| Marshall Wace, LLP | 323,211 | $1.71M | 0.00% | +248,652+333.5% | Added |
| Millennium Management LLC | 311,288 | $1.64M | 0.00% | +106,690+52.1% | Added |
| Susquehanna International Group, LLP | 218,962 | $1.16M | 0.00% | +193,312+753.7% | Added |
| State Street Corp | 178,246 | $941.1K | 0.00% | +57,943+48.2% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 137,031 | $723.5K | 0.00% | +53,809+64.7% | Added |
| Qube Research & Technologies Ltd | 127,332 | $672.3K | 0.00% | +127,332 | New |
| Bridgeway Capital Management, LLC | 127,300 | $672.1K | 0.01% | 00.0% | Unchanged |
| Citigroup Inc | 122,858 | $648.7K | 0.00% | +122,858 | New |
| Towerview LLC | 117,500 | $620.4K | 0.40% | −282,500−70.6% | Reduced |
| Northern Trust Corp | 105,450 | $556.8K | 0.00% | +22,460+27.1% | Added |
| Citadel Advisors LLC | 97,073 | $512.5K | 0.00% | +44,063+83.1% | Added |
| Acadian Asset Management LLC | 79,735 | $420.0K | 0.00% | +79,735 | New |
| Two Sigma Investments, LP | 71,552 | $377.8K | 0.00% | +23,766+49.7% | Added |
| Jackson Square Capital, LLC | 63,773 | $336.7K | 0.08% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 61,300 | $323.7K | 0.00% | −52,100−45.9% | Reduced |
| Jane Street Group, LLC | 50,221 | $265.2K | 0.00% | +50,221 | New |
| Hikari Power Ltd | 49,959 | $264.0K | 0.02% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 49,556 | $261.7K | 0.00% | +40,404+441.5% | Added |
| Mission Wealth Management, LP | 40,000 | $211.2K | 0.01% | +40,000 | New |
| Gillespie Robinson & Grimm Inc | 27,580 | $145.6K | 0.01% | +16,000+138.2% | Added |
| Ancora Advisors, LLC | 23,285 | $122.9K | 0.00% | +23,285 | New |
| Quinn Opportunity Partners LLC | 22,327 | $117.9K | 0.01% | 00.0% | Unchanged |
| Commerce Bank | 20,000 | $105.6K | 0.00% | 00.0% | Unchanged |
| American Century Companies Inc | 18,208 | $96.1K | 0.00% | −40−0.2% | Reduced |
| Oppenheimer & Co Inc | 16,947 | $89.5K | 0.00% | +16,947 | New |
| Advisor Group Holdings, Inc. | 16,734 | $88.4K | 0.00% | +16,200+3,033.7% | Added |
| Virtu Financial LLC | 15,694 | $83.0K | 0.00% | +15,694 | New |
| UBS Group AG | 15,681 | $82.8K | 0.00% | +2,681+20.6% | Added |
| Charles Schwab Investment Management Inc | 15,668 | $82.7K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 14,086 | $74.4K | 0.01% | +14,086 | New |
| Squarepoint Ops LLC | 12,080 | $63.8K | 0.00% | +12,080 | New |
| Dimensional Fund Advisors LP | 11,924 | $63.0K | 0.00% | 00.0% | Unchanged |
| Whittier Trust Co of Nevada Inc | 11,200 | $59.0K | 0.00% | 00.0% | Unchanged |
| Nwam LLC | 10,050 | $53.1K | 0.00% | +10,050 | New |
| Cubist Systematic Strategies, LLC | 10,026 | $52.9K | 0.00% | −14,338−58.8% | Reduced |
| Resources Investment Advisors, LLC. | 10,000 | $52.8K | 0.00% | −4,550−31.3% | Reduced |
| Masso Torrence Wealth Management Inc. | 10,000 | $52.8K | 0.03% | 00.0% | Unchanged |
| Rothschild Investment LLC | 7,000 | $37.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 5,560 | $29.4K | 0.00% | +5,560 | New |
| Simplex Trading, LLC | 5,670 | $29.0K | 0.00% | +3,458+156.3% | Added |
| Northwest Capital Management Inc | 3,397 | $17.9K | 0.01% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 3,110 | $16.4K | 0.00% | +3,110 | New |
| Western Pacific Wealth Management, LP | 2,000 | $10.6K | 0.01% | +2,000 | New |
| Rhumbline Advisers | 791 | $4.18K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 409 | $2.16K | 0.00% | +17+4.3% | Added |
| IFP Advisors, Inc | 24 | $127 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 20 | $106 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 10 | $51 | 0.00% | −43−81.1% | Reduced |
| Barclays PLC | 1 | $5 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −15,300−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,384−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −7,238−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |